ARTICLE | Clinical News
Aranesp darbepoetin alfa: Phase III data
January 21, 2013 8:00 AM UTC
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Product: Aranesp darbepoetin alfa ( NESP) ( KRN321) Business: Hematology Molecular target: Eryt...